Library of American University of Madaba
Your cart is empty.
Antithrombotic drug therapy in cardiovascular disease /
edited by Arman T. Askari, A. Michael Lincoff.
- Dordrecht ; Humana Press, 2010.
- xiii, 475 p. : ill. (some col.) ; 27 cm.
- Contemporary cardiology (Totowa, N.J. : Unnumbered) .
Includes bibliographical references and index.
Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs.
9781603272346 (hbk.) 1603272348 (hbk.)
Fibrinolytic agents.
Cardiovascular system--Diseases--Chemotherapy.
Cardiovascular Diseases--drug therapy.
Fibrinolytic Agents--therapeutic use.
Thrombolytic Therapy.
Thrombosis--drug therapy.
RC671.5
615.718 / A633
Includes bibliographical references and index.
Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs.
9781603272346 (hbk.) 1603272348 (hbk.)
Fibrinolytic agents.
Cardiovascular system--Diseases--Chemotherapy.
Cardiovascular Diseases--drug therapy.
Fibrinolytic Agents--therapeutic use.
Thrombolytic Therapy.
Thrombosis--drug therapy.
RC671.5
615.718 / A633